Observations on the use of rifampicin in apparently sulfone-resistant hanseniasis patients
DOI:
https://doi.org/10.47878/hi.1976.v1.35678Keywords:
Hanseniasis, Therapy, Rifampicin, DapsoneAbstract
study was made of the effects of rifampicin treatment on 10 sulfone resistant Virchowian patients. Clinical, bacilloscopical and histopathological observations were made as well as blood, urine and hepatic function tests. The results suggest that rifampicin is the preferred drug for the treatment of cases of sulf one resistant Virchowian hanseniasis.
Downloads
Download data is not yet available.
References
1. BARBOSA, A. A rifampicina (RIFADIN) no tratamento da lepra: ensaio efetuado em doentes do Hospital Rovisco Pais. (Tocha, Portugal) Rovisco Pais: rev. port. doença Hansen, 12:3-36, 1973.
2. CHANALET, G.; GUYON, J.; BEAUTE, J.; PARC, F.; BOUTIER, F. Premiers résultats du traitement de la lèpre en Nouvelle-Caledonie par rifampicine. Med. Trop., 32:203-215, 1972.
3. DAJANI, B. M.; CANADY, M. S.; THOMPSON, J. S.; KASIK, J. E. Rifampicin: an immunosupressant. Lancet (7787) :1094, 1972.
4. FURESZ, S.; SCOTTI, R.; PALLANZA, R.; MAPELLI, E. Rifampicin: a new rifamycin absortion, distribution and elimination in man. Arzneimittel-Forschung, 17:634, 1967.
5. HAZAMA, S. Therapeutic trial on the effect of rifampicin (RFP) combined with the standard DDS therapy for lepromatous leprosy. (Six months observation). In: JOINT LEPROSY RESEARCH CONFERENCE, 7th, Tokyo, 1972. Abstracts apud Int. J. Leprosy, 40(4): 458-459, 1972.
6. LANGUILLON, J. Note preliminaire sur le traitement de la lepre par la rifampicine. Medicine d'Afrique Noire, 18:273-281, 1971.
7. LEIKER, D. L. & KAMP, H. First results of treatment of leprosy with rifa- din. Leprosy Rev., 41:26-30, 1970.
8. OPROMOLLA, D. V. Primeiros resultados com a "Rifamicina SV" na lepra lepromatosa. In: CONGRESSO INTERNACIONAL DE LEPROLOGIA, 8.°, Rio de Janeiro, 1963. Anais. Rio de Janeiro, Serviço Nacional de Lepra, 1963. v. 2, p. 346-365.
9. PATTYN, S. R.; ROLLIER, R.; SAERENS, E. J.; ROLLIER, M. R. Initial three months continuous and intermittent therapy in lepromatous leprosy. A controlled clinical trial. Preliminary data. Ann. Soc. Belg. Med. Trop., 54(1) :43-49, 1974.
10. REES, R. J. W. Rifampicin as therapy in lepromatous leprosy. Star, 83 (4) : 5, 12, 1974.
11. REES, R. J. W.; PEARSON, J. M. H.; WATERS, M. F. R. Experimental and clinical studies on rifampicin in treatment of leprosy. Brit. Med. J., 1:89-92, 1970.
12. REES, R. J. W. & WATERS, M. F. R. Recent trends in leprosy research. Br. Med. Bull., 28 (1) :16-21, 1972.
13. REPORT of congress committees. Committee 6: therapy. In: INTERNATIONAL LEPROSY CONGRESS, 10th, Bergen, 1973. Transactions apud Int. J. Leprosy, 41(4) :462-465, 1973.
14. SERAFINO, A. & SILVESTRE, N. Ensayos preliminares del uso de la rifampicina en lepra. Semana Med., 142(7) :258-259, 1973.
15. SHEPARD, C. C.; LEVY, L.; FASAL, P. Rapid bactericidal effect of rifampicin on Mycobacterium leprae. Am. J. Trop. Med. Hyg., 21 (4) :446-449, 1972.
16. SHEPARD, C. C.; LEVY, L.; FASAL, P. Rifampin and M. leprae. In: JOINT LEPROSY RESEARCH CONFERENCE, 7th, Tokyo, 1972. Abstracts apud Int. J. Leprosy, 40(4) :459-460, 1972.
17. SOUZA LIMA, L. & ARANTES, F. Resistência do bacilo de Hansen à quimioterapia. In: CONGRESSO INTERNACIONAL DE LEPROLOGIA, 8.°, Rio de Janeiro, 1963. Anais. Rio de Janeiro, Serviço Nacional de Lepra, 1963. v. 2, p. 414-437.
18. TERENCIO DE LAS AGUAS, J. & RICHERI, D. Tratamiento de la lepra con rifampicina. Rev. Leprol. Fontilles, 9 (4) :365-373, 1974.
19. TRIMIGLIOZZI, G.; MENEGHINI, C. L.; LOSPALLUTI, M.; ANGELINI, G. Osservazioni preliminari sulla terapia della lebbra con rifampicina. G. Ital. Dermatol., 45-111 (3) :215-216, 1970.
2. CHANALET, G.; GUYON, J.; BEAUTE, J.; PARC, F.; BOUTIER, F. Premiers résultats du traitement de la lèpre en Nouvelle-Caledonie par rifampicine. Med. Trop., 32:203-215, 1972.
3. DAJANI, B. M.; CANADY, M. S.; THOMPSON, J. S.; KASIK, J. E. Rifampicin: an immunosupressant. Lancet (7787) :1094, 1972.
4. FURESZ, S.; SCOTTI, R.; PALLANZA, R.; MAPELLI, E. Rifampicin: a new rifamycin absortion, distribution and elimination in man. Arzneimittel-Forschung, 17:634, 1967.
5. HAZAMA, S. Therapeutic trial on the effect of rifampicin (RFP) combined with the standard DDS therapy for lepromatous leprosy. (Six months observation). In: JOINT LEPROSY RESEARCH CONFERENCE, 7th, Tokyo, 1972. Abstracts apud Int. J. Leprosy, 40(4): 458-459, 1972.
6. LANGUILLON, J. Note preliminaire sur le traitement de la lepre par la rifampicine. Medicine d'Afrique Noire, 18:273-281, 1971.
7. LEIKER, D. L. & KAMP, H. First results of treatment of leprosy with rifa- din. Leprosy Rev., 41:26-30, 1970.
8. OPROMOLLA, D. V. Primeiros resultados com a "Rifamicina SV" na lepra lepromatosa. In: CONGRESSO INTERNACIONAL DE LEPROLOGIA, 8.°, Rio de Janeiro, 1963. Anais. Rio de Janeiro, Serviço Nacional de Lepra, 1963. v. 2, p. 346-365.
9. PATTYN, S. R.; ROLLIER, R.; SAERENS, E. J.; ROLLIER, M. R. Initial three months continuous and intermittent therapy in lepromatous leprosy. A controlled clinical trial. Preliminary data. Ann. Soc. Belg. Med. Trop., 54(1) :43-49, 1974.
10. REES, R. J. W. Rifampicin as therapy in lepromatous leprosy. Star, 83 (4) : 5, 12, 1974.
11. REES, R. J. W.; PEARSON, J. M. H.; WATERS, M. F. R. Experimental and clinical studies on rifampicin in treatment of leprosy. Brit. Med. J., 1:89-92, 1970.
12. REES, R. J. W. & WATERS, M. F. R. Recent trends in leprosy research. Br. Med. Bull., 28 (1) :16-21, 1972.
13. REPORT of congress committees. Committee 6: therapy. In: INTERNATIONAL LEPROSY CONGRESS, 10th, Bergen, 1973. Transactions apud Int. J. Leprosy, 41(4) :462-465, 1973.
14. SERAFINO, A. & SILVESTRE, N. Ensayos preliminares del uso de la rifampicina en lepra. Semana Med., 142(7) :258-259, 1973.
15. SHEPARD, C. C.; LEVY, L.; FASAL, P. Rapid bactericidal effect of rifampicin on Mycobacterium leprae. Am. J. Trop. Med. Hyg., 21 (4) :446-449, 1972.
16. SHEPARD, C. C.; LEVY, L.; FASAL, P. Rifampin and M. leprae. In: JOINT LEPROSY RESEARCH CONFERENCE, 7th, Tokyo, 1972. Abstracts apud Int. J. Leprosy, 40(4) :459-460, 1972.
17. SOUZA LIMA, L. & ARANTES, F. Resistência do bacilo de Hansen à quimioterapia. In: CONGRESSO INTERNACIONAL DE LEPROLOGIA, 8.°, Rio de Janeiro, 1963. Anais. Rio de Janeiro, Serviço Nacional de Lepra, 1963. v. 2, p. 414-437.
18. TERENCIO DE LAS AGUAS, J. & RICHERI, D. Tratamiento de la lepra con rifampicina. Rev. Leprol. Fontilles, 9 (4) :365-373, 1974.
19. TRIMIGLIOZZI, G.; MENEGHINI, C. L.; LOSPALLUTI, M.; ANGELINI, G. Osservazioni preliminari sulla terapia della lebbra con rifampicina. G. Ital. Dermatol., 45-111 (3) :215-216, 1970.
Downloads
Published
1976-06-30
How to Cite
1.
BELDA W, MENDES JP, MARGARIDO LC, MARTINEZ EALW. Observations on the use of rifampicin in apparently sulfone-resistant hanseniasis patients. Hansen. Int. [Internet]. 1976 Jun. 30 [cited 2024 Jul. 22];1(1):79-91. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35678
Issue
Section
Artigos de investigação científica
License
This journal is licensed under a Creative Commons Attribution 4.0 International License.
